findmyKOL

Emily Baumrin, MD

Basic profile

University of Pennsylvania

ORCIDNPI
RegionPhiladelphia, PA · NortheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2025–2026Why? →

Emily Baumrin is a Dermatology physician affiliated with University of Pennsylvania. OpenAlex indexes 42 publications with 562 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
42publications

Distinct works indexed by OpenAlex, matched via ORCID.

562citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2025–2026

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    37.2%
    Interleukin-4 Receptor alpha Antagonist19.1%
    Dupixent Syringe62%Dupixent Pen38%
    Part D<11 patients
    Corticosteroid18.1%
    Triamcinolone Acetonide75%Desoximetasone25%
    Part D<11 patients
  • Sensory organs

    14.6%
    Corticosteroid14.6%
    Clobetasol Propionate100%
    Part D17 patients
  • Metabolism & gastrointestinal

    12.5%
    Corticosteroid12.5%
    Prednisone100%
    Part D11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20252026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”